Related Experiment Video

Updated: Aug 29, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

Effects of monochlorobimane on cerebral ischemia-induced damage to mitochondria

Sayuri Oshikawa1, Keiko Miyake-Takagi, Norio Takagi

  • 1Department of Pharmacology, Tokyo University of Pharmacy & Life Science, Hachioji, Tokyo 192-0392, Japan.

Biological & Pharmaceutical Bulletin
|February 6, 2004
PubMed

Insights

Monochlorobimane (MCB) inhibits mitochondrial permeability transition (MPT) pore opening, offering cerebroprotection against ischemic brain injury. This finding suggests MCB

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Ischemic brain injury is a significant cause of mortality and disability.
  • Mitochondrial dysfunction, particularly the opening of the permeability transition pore (MPT), plays a critical role in ischemic brain injury.
  • Cerebroprotection strategies often target mitochondrial pathways.

Purpose of the Study:

  • To investigate the potential cerebroprotective effects of monochlorobimane (MCB).
  • To examine the role of MCB in inhibiting the opening of the mitochondrial permeability transition (MPT) pore.
  • To assess MCB's impact on mitochondrial activity following experimental ischemic brain injury.

Main Methods:

  • In vitro inhibition of MPT pore opening by MCB.
  • Induction of sustained cerebral ischemia in rats using microsphere embolism (ME).
  • Histochemical staining for cytochrome c oxidase (COX) and succinate dehydrogenase (SDH) to assess mitochondrial activity in brain sections at various time points post-ME.

Main Results:

  • MCB (1 mM) demonstrated in vitro inhibition of MPT pore opening.
  • MCB pretreatment significantly attenuated the reduction in COX and SDH staining in the hippocampus following ME.
  • The protective effect of MCB was observed in the hippocampus but not the parietal cortex.

Conclusions:

  • Inhibition of MPT pore opening by MCB may be a key mechanism for its cerebroprotective effects.
  • MCB shows promise as a therapeutic agent for mitigating ischemic brain injury.
  • Targeting MPT pore opening represents a viable strategy for cerebroprotection.

Related Concept Videos

Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...